Skip to main content
HCWB filings

Corporate insider profile

Rebecca Byam Filing Activity

Latest reported as Chief Financial Officer of HCW Biologics Inc. (HCWB).

Purchase filings
1
Reported companies
1
Net open-market value
$20,000
Latest transaction
May 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 22, 2026HCW Biologics Inc. (HCWB)Chief Financial OfficerOpen Market Purchase14,235$1.41$20,000